Literature DB >> 22082604

Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases.

Seung-Mo Hong1, Michael Goggins, Christopher L Wolfgang, Richard D Schulick, Barish H Edil, John L Cameron, Adriana Handra-Luca, Joseph M Herman, Ralph H Hruban.   

Abstract

Although vascular invasion is a well-established indicator of poor prognosis for patients with infiltrating ductal adenocarcinoma of the pancreas (PDAC), the histopathologic characteristics of vascular invasion are not well described. Hematoxylin and eosin-stained slides from 209 surgically resected infiltrating PDACs were systematically evaluated for the presence or absence of microscopic vascular invasion. For the cases with vascular invasion, we further categorized the histologic pattern of invasion into conventional and pancreatic intraepithelial neoplasia-like (PanIN-like). In addition, several histopathologic factors in the surrounding blood vessels, including lymphocytic infiltration and luminal fibrosis, were carefully assessed. Data were compared with clinicopathologic variables, including patient survival. Microscopic vascular invasion was observed in 136 of the 209 PDACs (65.1%). Vascular invasion mimicking pancreatic intraepithelial neoplasia (PanIN-like invasion) was observed in 94 of the 136 cases (69.1%) with vascular invasion. Microscopic vascular invasion was associated with increased tumor size (P=0.04), higher pT classification (P=0.003), lymph node metastasis (P<0.0001), and perineural invasion (P=0.005). Vascular invasion was inversely correlated with neo-adjuvant therapy (P<0.0001). Examination of adjacent blood vessels revealed that peritumoral blood vessels with intimal lymphocytes (P=0.002), intimal (P=0.007) and medial (P=0.001) fibrosis, and cancer cells in vascular wall (P<0.0001) were all highly associated with the intraluminal vascular invasion. In univariate analysis, patients whose cancers had microscopic vascular invasion (median survival, 15.3 mo) had a significantly worse survival than did patients with carcinomas without vascular invasion (25.1 mo; P=0.01, log-rank test). Microscopic vascular invasion is a poor prognostic indicator and can histologically mimic PanIN.

Entities:  

Mesh:

Year:  2012        PMID: 22082604      PMCID: PMC3261341          DOI: 10.1097/PAS.0b013e3182376e36

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

2.  Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.

Authors:  Hanno Matthaei; Seung-Mo Hong; Skye C Mayo; Marco dal Molin; Kelly Olino; Raghunandan Venkat; Michael Goggins; Joseph M Herman; Barish H Edil; Christopher L Wolfgang; John L Cameron; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

3.  Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.

Authors:  Aleodor Andea; Fazlul Sarkar; Volkan N Adsay
Journal:  Mod Pathol       Date:  2003-10       Impact factor: 7.842

4.  Update on pancreatic intraepithelial neoplasia.

Authors:  Ralph H Hruban; Anirban Maitra; Michael Goggins
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region.

Authors:  J H Allema; M E Reinders; T M van Gulik; M J Koelemay; D J Van Leeuwen; L T de Wit; D J Gouma; H Obertop
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

6.  Prognostic factors for radical resection of middle and distal bile duct cancer.

Authors:  Tatsuya Nomura; Yoshiaki Tsuchiya; Atsushi Nashimoto; Hiroshi Yabusaki; Yasumasa Takii; Satoru Nakagawa; Nobuaki Sato; Chizuko Kanbayashi; Otsuo Tanaka
Journal:  Hepatogastroenterology       Date:  2009 Mar-Apr

Review 7.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Factors associated with survival after surgical resection in Chinese patients with ductal adenocarcinoma of the pancreatic head.

Authors:  Qiang Li; Chuntao Gao; Huikai Li; Jonathan T Juzi; Hua Chen; Xishan Hao
Journal:  Dig Surg       Date:  2008-03-21       Impact factor: 2.588

9.  Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.

Authors:  G Garcea; A R Dennison; S L Ong; C J Pattenden; C P Neal; C D Sutton; C D Mann; D P Berry
Journal:  Eur J Surg Oncol       Date:  2007-03-29       Impact factor: 4.424

10.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

View more
  13 in total

Review 1.  Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Authors:  Daniel Åkerberg; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 2.  Adenocarcinoma of the pancreas.

Authors:  Ralph H Hruban; David S Klimstra
Journal:  Semin Diagn Pathol       Date:  2014-09-02       Impact factor: 3.464

Review 3.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

4.  Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News.

Authors:  Ralph H Hruban
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

5.  THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.

Authors:  Shirsa Udgata; Naomi Takenaka; William R Bamlet; Ann L Oberg; Stephanie S Yee; Erica L Carpenter; Daniel Herman; Jungsun Kim; Gloria M Petersen; Kenneth S Zaret
Journal:  Cancer Prev Res (Phila)       Date:  2020-10-16

Review 6.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

7.  Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Huangbao Li; Weiwei Pan; Liu Xu; Dong Yin; Shuqun Cheng; Fengqing Zhao
Journal:  Med Sci Monit       Date:  2021-08-16

8.  Radical resection of T1 pancreatic adenocarcinoma with a pseudocyst of the tail due to acute obstructive pancreatitis: report of a case.

Authors:  Yuki Fujiwara; Fumitake Suzuki; Masaru Kanehira; Yasuro Futagawa; Tomoyoshi Okamoto; Katsuhiko Yanaga
Journal:  Surg Case Rep       Date:  2016-11-30

9.  Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.

Authors:  Danielle Hutchings; Kevin M Waters; Matthew J Weiss; Christopher L Wolfgang; Martin A Makary; Jin He; John L Cameron; Laura D Wood; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2018-11       Impact factor: 6.394

10.  Pancreatic cancer survival analysis defines a signature that predicts outcome.

Authors:  Pichai Raman; Ravikanth Maddipati; Kian Huat Lim; Aydin Tozeren
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.